SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-020663
Filing Date
2020-03-23
Accepted
2020-03-23 16:45:29
Documents
2
Period of Report
2020-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4017
2 EX-24 DOCUMENT attachment1.htm EX-24 7423
  Complete submission text file 0001209191-20-020663.txt   13040
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O KYTHERA BIOPHARMACEUTICALS, INC. 30930 RUSSELL RANCH ROAD, 3RD FLOOR WESTLAKE VILLAGE CA 91362
Business Address
Sandoval Elisabeth (Reporting) CIK: 0001632295 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 20735390